Skip to content
10-Q

Quarterly Report

ALNYLAM PHARMACEUTICALS, INC. ALNY

0001178670-25-000090

← back to feed
Filed
Jul 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 25, 2025 131.08M sh
Shares Diluted Q2 2025 · Jun 30, 2025 130.63M sh
Shares Diluted Q2 2025 · Jun 30, 2025 130.16M sh
Shares Diluted Q2 2025 · Jun 30, 2024 126.73M sh
Shares Diluted Q2 2025 · Jun 30, 2024 126.44M sh
Capex Q2 2025 · Jun 30, 2025 $23.26M
Capex Q2 2025 · Jun 30, 2024 $20.99M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $35.42M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $42.64M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.11B
Cash And Equivalents Q2 2025 · Dec 31, 2024 $966.43M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $968.49M
Stockholders Equity Q2 2025 · Jun 30, 2025 $250.59M
Stockholders Equity Q2 2025 · Mar 31, 2025 $115.44M
Stockholders Equity Q2 2025 · Dec 31, 2024 $67.09M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$3.07M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$219.27M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$220.64M
Current Liabilities Q2 2025 · Jun 30, 2025 $1.3B
Current Liabilities Q2 2025 · Dec 31, 2024 $1.19B
Total Liabilities Q2 2025 · Jun 30, 2025 $4.32B
Total Liabilities Q2 2025 · Dec 31, 2024 $4.17B
Current Assets Q2 2025 · Jun 30, 2025 $3.64B
Current Assets Q2 2025 · Dec 31, 2024 $3.3B
Total Assets Q2 2025 · Jun 30, 2025 $4.57B
Total Assets Q2 2025 · Dec 31, 2024 $4.24B
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.51
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.95
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.13
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.66
Eps Basic Q2 2025 · Jun 30, 2025 −$0.51
Eps Basic Q2 2025 · Jun 30, 2025 −$0.95
Eps Basic Q2 2025 · Jun 30, 2024 −$0.13
Eps Basic Q2 2025 · Jun 30, 2024 −$0.66
Sga Expense Q2 2025 · Jun 30, 2025 $323.31M
Sga Expense Q2 2025 · Jun 30, 2025 $563.26M
Sga Expense Q2 2025 · Jun 30, 2024 $248.4M
Sga Expense Q2 2025 · Jun 30, 2024 $459.19M
Rd Expense Q2 2025 · Jun 30, 2025 $323.62M
Rd Expense Q2 2025 · Jun 30, 2025 $588.74M
Rd Expense Q2 2025 · Jun 30, 2024 $294.14M
Rd Expense Q2 2025 · Jun 30, 2024 $555.14M
Net Income Q2 2025 · Jun 30, 2025 −$66.28M
Net Income Q2 2025 · Jun 30, 2025 −$123.76M
Net Income Q2 2025 · Mar 31, 2025 −$57.48M
Net Income Q2 2025 · Jun 30, 2024 −$16.89M
Net Income Q2 2025 · Jun 30, 2024 −$82.82M
Net Income Q2 2025 · Mar 31, 2024 −$65.94M
Operating Income Q2 2025 · Jun 30, 2025 −$16.2M
Operating Income Q2 2025 · Jun 30, 2025 $1.88M
Operating Income Q2 2025 · Jun 30, 2024 $48.61M
Operating Income Q2 2025 · Jun 30, 2024 $5.18M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $142.03M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $212.21M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $67.27M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $121.88M
Revenue Q2 2025 · Jun 30, 2025 $773.69M
Revenue Q2 2025 · Jun 30, 2025 $1.37B
Revenue Q2 2025 · Jun 30, 2024 $659.83M
Revenue Q2 2025 · Jun 30, 2024 $1.15B